F-group (family)
5050.1.1.1 Sugar_tr
Ligands and drugs
2,531
Member domains
169
with ligand contacts (≤ 4 Å)
6.7% of members
74
with DrugDomain annotations
2.9% of members
40
with a DrugBank compound
1.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5050.1.1.1 belongs to X-group 5050 Major facilitator superfamily (MFS) general substrate transporter, which binds 9.9 ligand superclasses per 20 proteins, broader than 93% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02379 | BGC | Beta-D-Glucose | 18 |
| DB02451 | BNG | B-nonylglucoside | 14 |
| DB16766 | 5RH | Cytochalasin B | 6 |
| DB00428 | — | — | 2 |
| DB00583 | — | — | 2 |
| DB02709 | — | Resveratrol | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| BNG | nonyl beta-D-glucopyranoside | 34 |
| BGC | beta-D-glucopyranose | 27 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 16 |
| GLC | alpha-D-glucopyranose | 12 |
| CL | CHLORIDE ION | 10 |
| URC | URIC ACID | 9 |
| A1IVP | 2.5-anhydro-D-mannitol | 8 |
| CDmetal | CADMIUM ION | 7 |
| MF8 | Metformin | 7 |
| 5RH | Cytochalasin B | 6 |
| F00 | (2S,3R,4S,5R,6R)-6-(hydroxymethyl)-4-undec-10-enoxy-oxane-2,3,5-triol | 6 |
| RTO | 4-(dipropylsulfamoyl)benzoic acid | 6 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 5 |
| 37X | Octyl Glucose Neopentyl Glycol | 4 |
| A0E | methyl N-[(2-{4-[4-(5-fluoro-2-methoxyphenyl)piperazin-1-yl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}phenyl)methyl]-beta-alaninate | 4 |
| OLM | Olmesartan | 4 |
| SNL | SPIRONOLACTONE | 4 |
| A1AIJ | verinurad | 3 |
| NAmetal | SODIUM ION | 3 |
| VGL | PYRAZINE-2-CARBOXYLIC ACID | 3 |